Organization Profile

You just read:

Indivior Announces New Drug Submission to Health Canada for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Moderate to Severe Opioid Use Disorder

News provided by

Indivior

Apr 20, 2018, 09:00 ET